Status:
COMPLETED
Focus on the Humeral Component Following Reverse Shoulder Arthroplasty
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Rotator Cuff Arthropathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Reverse total shoulder arthroplasty has been widely used in the treatment of rotator cuff arthropathy. Follow-up has historically focused on the glenoid component because of problems with fixation and...
Detailed Description
Reverse total shoulder arthroplasty has been widely used in the treatment of rotator cuff arthropathy. Follow-up has historically focused on the glenoid component because of problems with fixation and...
Eligibility Criteria
Inclusion
- Minimum age of 18 years old
- Total shoulder replacement using a reverse type implant (Delta Xtend or Zimmer TM) between 2007 and 2017 in UZ Leuven
- Primary indication for surgery is rotator cuff arthropathy
- Informed consent obtained
Exclusion
- Total shoulder replacement in post septic arthritis.
- Total shoulder replacement in post-instability arthritis.
- Revision total shoulder arthroplasty.
- Posttraumatic total shoulder arthroplasty (after failed index operation)
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT04809077
Start Date
June 1 2021
End Date
April 1 2024
Last Update
June 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Vlaams-Brabant, Belgium, 3000